Skip to main content


We're creating a new version of this page. See preview

  • Poster presentation
  • Open Access

Increased expression of A-kinase anchoring proteins in T cells from systemic lupus erythematosus patients

  • 1,
  • 1,
  • 1 and
  • 1
Journal of Translational Medicine20108 (Suppl 1) :P49

  • Published:


  • Western Blot
  • Protein Kinase
  • Protein Level
  • Systemic Lupus Erythematosus
  • Systemic Lupus Erythematosus Patient


Deficient activation of protein kinase A (PKA) is a characteristic of T cells in systemic lupus erythematosus (SLE). A-kinase Anchoring Proteins (AKAPs) associate to and regulate the activity of PKA [1]. Furthermore, some AKAPs are expressed in T cells and influence their function [2]. Therefore, altered expression and/or function of AKAPs can play a role in the deregulated activity of PKA observed in SLE T cells.


To analyse the expression of different AKAPs in T cells isolated from SLE patients.

Patients and methods

T cells were isolated by negative selection using magnetic beads from SLE patients (n= 12) and healthy controls (HC, n= 12). RNA was purified and levels of AKAP79, AKAP95 and AKAP450 mRNA were quantified by RT-qPCR. Subsequently, the analysis of AKAP79 expression was extended to include a total of 24 SLE patients and19 HC. In addition, AKAP79 protein was detected by Western Blot and quantified with Quantity One software.


Levels of AKAP450 mRNA were comparable in HC and SLE T cells (10.73 +/- 0.73 (HC, n= 12) vs 12.69 +/- 1.09 (SLE, n= 12), P= 0.15). However, T Cells from SLE patients had significantly higher levels of AKAP79 and AKAP95 mRNA than HC (AKAP79: 1.99 +/- 0.29 (HC, n= 19) vs 3.61 +/- 0.72 (SLE, n= 24), P= 0.04; AKAP95: 2.58 +/- 0.18 (HC, n= 12) vs 4.13 +/- 0.31 (SLE, n= 12), P= 0.0005). Analysis of AKAP79 protein levels showed increased levels of AKAP79 in SLE T cells compared to HC T cells (0.38 ± 0.05 (HC) vs 0.75 ± 0.18 (SLE), P= 0.06).


Increased levels of AKAP79 and AKAP95 in T cells from SLE patients can contribute to the deregulation of PKA activity in these cells.

Authors’ Affiliations

Centro de Investigación y Servicio de Reumatología, Hospital 12 de Octubre, Instituto de Investigación Sanitaria “I + 12”, Madrid, Spain


  1. Jarnaess E, Taskén K: Spatiotemporal control of cAMP signalling processes by anchored signalling complexes. Biochem Soc Trans. 2007, 35: 931-7. 10.1042/BST0350931.View ArticlePubMedGoogle Scholar
  2. Schillace RV, Carr SD: The role of Protein Kinase A and A Kinase Anchoring proteins in modulating T cell activation: Progress and future directions. Crit Rev Immunol. 2006, 26: 113-31.View ArticlePubMedGoogle Scholar


© Criado et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd.